CRITEO SA-SPON ADR (CRTO)

US2267181046 - ADR

41  -1.23 (-2.91%)

Fundamental Rating

5

CRTO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 91 industry peers in the Media industry. CRTO has an average financial health and profitability rating. CRTO scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, CRTO could be worth investigating further for value investing!.



6

1. Profitability

1.1 Basic Checks

CRTO had positive earnings in the past year.
CRTO had a positive operating cash flow in the past year.
Each year in the past 5 years CRTO has been profitable.
In the past 5 years CRTO always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of CRTO (4.60%) is better than 77.78% of its industry peers.
The Return On Equity of CRTO (9.65%) is better than 80.00% of its industry peers.
CRTO's Return On Invested Capital of 9.37% is amongst the best of the industry. CRTO outperforms 86.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRTO is in line with the industry average of 6.93%.
The 3 year average ROIC (6.33%) for CRTO is below the current ROIC(9.37%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.6%
ROE 9.65%
ROIC 9.37%
ROA(3y)3.12%
ROA(5y)3.66%
ROE(3y)5.79%
ROE(5y)6.56%
ROIC(3y)6.33%
ROIC(5y)7.5%

1.3 Margins

With a decent Profit Margin value of 5.21%, CRTO is doing good in the industry, outperforming 70.00% of the companies in the same industry.
CRTO's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 7.52%, CRTO is in line with its industry, outperforming 54.44% of the companies in the same industry.
CRTO's Operating Margin has declined in the last couple of years.
The Gross Margin of CRTO (49.25%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CRTO has grown nicely.
Industry RankSector Rank
OM 7.52%
PM (TTM) 5.21%
GM 49.25%
OM growth 3Y-6.2%
OM growth 5Y-4.49%
PM growth 3Y-7.57%
PM growth 5Y-6.64%
GM growth 3Y10.07%
GM growth 5Y4.07%

6

2. Health

2.1 Basic Checks

CRTO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CRTO has less shares outstanding
Compared to 5 years ago, CRTO has less shares outstanding
The debt/assets ratio for CRTO is higher compared to a year ago.

2.2 Solvency

CRTO has an Altman-Z score of 2.72. This is not the best score and indicates that CRTO is in the grey zone with still only limited risk for bankruptcy at the moment.
CRTO has a Altman-Z score of 2.72. This is amongst the best in the industry. CRTO outperforms 81.11% of its industry peers.
The Debt to FCF ratio of CRTO is 0.03, which is an excellent value as it means it would take CRTO, only 0.03 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.03, CRTO belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
CRTO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CRTO's Debt to Equity ratio of 0.00 is amongst the best of the industry. CRTO outperforms 87.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 2.72
ROIC/WACC1.2
WACC7.78%

2.3 Liquidity

A Current Ratio of 1.17 indicates that CRTO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.17, CRTO is doing worse than 63.33% of the companies in the same industry.
CRTO has a Quick Ratio of 1.17. This is a normal value and indicates that CRTO is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CRTO (1.17) is worse than 61.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 74.40% over the past year.
CRTO shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.93% yearly.
Looking at the last year, CRTO shows a decrease in Revenue. The Revenue has decreased by -0.05% in the last year.
The Revenue has been decreasing by -3.26% on average over the past years.
EPS 1Y (TTM)74.4%
EPS 3Y13.59%
EPS 5Y4.93%
EPS Q2Q%35.21%
Revenue 1Y (TTM)-0.05%
Revenue growth 3Y-2.02%
Revenue growth 5Y-3.26%
Sales Q2Q%8.44%

3.2 Future

CRTO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.95% yearly.
The Revenue is expected to grow by 8.67% on average over the next years. This is quite good.
EPS Next Y34.02%
EPS Next 2Y17.69%
EPS Next 3Y14.22%
EPS Next 5Y3.95%
Revenue Next Year11.1%
Revenue Next 2Y8.54%
Revenue Next 3Y8.67%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.40, the valuation of CRTO can be described as very reasonable.
Based on the Price/Earnings ratio, CRTO is valued cheaper than 81.11% of the companies in the same industry.
CRTO is valuated cheaply when we compare the Price/Earnings ratio to 27.54, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 9.31 indicates a reasonable valuation of CRTO.
CRTO's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRTO is cheaper than 84.44% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.99. CRTO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.4
Fwd PE 9.31

4.2 Price Multiples

CRTO's Enterprise Value to EBITDA ratio is in line with the industry average.
CRTO's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CRTO is cheaper than 65.56% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13
EV/EBITDA 8.77

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRTO may justify a higher PE ratio.
CRTO's earnings are expected to grow with 14.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)1.91
EPS Next 2Y17.69%
EPS Next 3Y14.22%

0

5. Dividend

5.1 Amount

No dividends for CRTO!.
Industry RankSector Rank
Dividend Yield N/A

CRITEO SA-SPON ADR

NASDAQ:CRTO (12/24/2024, 8:05:00 PM)

41

-1.23 (-2.91%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)10-30 2024-10-30/bmo
Earnings (Next)02-05 2025-02-05/amc
Inst Owners93.23%
Inst Owner Change6.04%
Ins Owners2.25%
Ins Owner Change-0.61%
Market Cap2.26B
Analysts80
Price Target52.96 (29.17%)
Short Float %5.58%
Short Ratio6.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.69%
Min EPS beat(2)13.45%
Max EPS beat(2)37.93%
EPS beat(4)4
Avg EPS beat(4)29.81%
Min EPS beat(4)13.45%
Max EPS beat(4)46.22%
EPS beat(8)7
Avg EPS beat(8)27.33%
EPS beat(12)11
Avg EPS beat(12)25.4%
EPS beat(16)15
Avg EPS beat(16)28.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.28%
Max Revenue beat(2)-0.67%
Revenue beat(4)2
Avg Revenue beat(4)0.53%
Min Revenue beat(4)-2.28%
Max Revenue beat(4)3.39%
Revenue beat(8)6
Avg Revenue beat(8)13.09%
Revenue beat(12)10
Avg Revenue beat(12)48.67%
Revenue beat(16)14
Avg Revenue beat(16)77.12%
PT rev (1m)-8.91%
PT rev (3m)-7.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.4%
EPS NY rev (1m)0%
EPS NY rev (3m)0.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.61%
Valuation
Industry RankSector Rank
PE 9.4
Fwd PE 9.31
P/S 1.16
P/FCF 13
P/OCF 9.05
P/B 2.15
P/tB 6.38
EV/EBITDA 8.77
EPS(TTM)4.36
EY10.63%
EPS(NY)4.4
Fwd EY10.74%
FCF(TTM)3.15
FCFY7.69%
OCF(TTM)4.53
OCFY11.05%
SpS35.28
BVpS19.05
TBVpS6.42
PEG (NY)0.28
PEG (5Y)1.91
Profitability
Industry RankSector Rank
ROA 4.6%
ROE 9.65%
ROCE 11.86%
ROIC 9.37%
ROICexc 11.54%
ROICexgc 37.89%
OM 7.52%
PM (TTM) 5.21%
GM 49.25%
FCFM 8.94%
ROA(3y)3.12%
ROA(5y)3.66%
ROE(3y)5.79%
ROE(5y)6.56%
ROIC(3y)6.33%
ROIC(5y)7.5%
ROICexc(3y)10.15%
ROICexc(5y)11.97%
ROICexgc(3y)30.69%
ROICexgc(5y)30.93%
ROCE(3y)8.01%
ROCE(5y)9.49%
ROICexcg growth 3Y11%
ROICexcg growth 5Y-7.74%
ROICexc growth 3Y-13.23%
ROICexc growth 5Y-14.21%
OM growth 3Y-6.2%
OM growth 5Y-4.49%
PM growth 3Y-7.57%
PM growth 5Y-6.64%
GM growth 3Y10.07%
GM growth 5Y4.07%
F-Score7
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA 0
Cap/Depr 91.47%
Cap/Sales 3.91%
Interest Coverage 99.46
Cash Conversion 108.96%
Profit Quality 171.42%
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 2.72
F-Score7
WACC7.78%
ROIC/WACC1.2
Cap/Depr(3y)91.65%
Cap/Depr(5y)87.78%
Cap/Sales(3y)4.17%
Cap/Sales(5y)4.02%
Profit Quality(3y)744%
Profit Quality(5y)506.88%
High Growth Momentum
Growth
EPS 1Y (TTM)74.4%
EPS 3Y13.59%
EPS 5Y4.93%
EPS Q2Q%35.21%
EPS Next Y34.02%
EPS Next 2Y17.69%
EPS Next 3Y14.22%
EPS Next 5Y3.95%
Revenue 1Y (TTM)-0.05%
Revenue growth 3Y-2.02%
Revenue growth 5Y-3.26%
Sales Q2Q%8.44%
Revenue Next Year11.1%
Revenue Next 2Y8.54%
Revenue Next 3Y8.67%
Revenue Next 5YN/A
EBIT growth 1Y169.95%
EBIT growth 3Y-8.09%
EBIT growth 5Y-7.6%
EBIT Next Year111.41%
EBIT Next 3Y34.81%
EBIT Next 5Y20.93%
FCF growth 1Y27.08%
FCF growth 3Y-2.36%
FCF growth 5Y-4.05%
OCF growth 1Y27.25%
OCF growth 3Y6.55%
OCF growth 5Y-2.97%